SCHEMBL23225599

SCHEMBL23225599

CC(C)OCCn1c(=S)[nH]c(=O)c2c1ccn2COC=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MPO P05164 2/20 0.54
▸ OPRM1 P35372 1/20 0.54
▸ ALDH1A1 P00352 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ TSHR P16473 1/20 0.33
▸ RAB9A P51151 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ CASP1 P29466 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ CASP7 P55210 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ PLK1 P53350 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27101979 0.88 MPO (0.57) MPOOPRM1ALDH1A1CYP1A2CYP2C9
SCHEMBL23225719 0.87 MPO (0.56) MPOOPRM1ALDH1A1CYP1A2CYP2C9
SCHEMBL23217965 0.84 MPO (0.58) MPOOPRM1ALDH1A1CYP1A2CYP2C9
SCHEMBL27103736 0.84 MPO (0.53) MPOOPRM1ALDH1A1CYP1A2CYP2C9
SCHEMBL28896616 0.84 MPO (0.57) MPOOPRM1ALDH1A1CYP1A2CYP2C9
SCHEMBL23225611 0.83 MPO (0.52) MPOOPRM1ALDH1A1CYP1A2CYP2C9
SCHEMBL23217981 0.83 MPO (0.52) MPOOPRM1ALDH1A1CYP1A2CYP2C9
SCHEMBL27101983 0.82 MPO (0.51) MPOOPRM1ALDH1A1CYP1A2CYP2C9
SCHEMBL23225612 0.82 MPO (0.50) MPOOPRM1ALDH1A1CYP1A2CYP2C9
SCHEMBL27103731 0.82 MPO (0.50) MPOOPRM1ALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021072140-A1 PRODRUGS OF MYELOPEROXIDASE INHIBITORS BIOHAVEN THERAPEUTICS LTD. (US) 2021-04-15 — — WO disclosed
Send feedback